BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23747516)

  • 21. Monocytes as a site of production of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in the septic host.
    Plachouras D; Routsi C; Giamarellos-Bourboulis EJ; Spyridaki E; Andrianakis I; Metzelopoulos S; Tsaganos T; Floros I; Douzinas EE; Armaganidis A; Roussos C; Giamarellou H
    Scand J Infect Dis; 2006; 38(10):909-15. PubMed ID: 17008237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
    Roger T; Glauser MP; Calandra T
    J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous HMGB1 is required in endotoxin tolerance.
    Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
    J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):277-84. PubMed ID: 9523001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis.
    Tsuchihashi H; Yamamoto H; Maeda K; Ugi S; Mori T; Shimizu T; Endo Y; Hanasawa K; Tani T
    J Surg Res; 2006 Aug; 134(2):348-53. PubMed ID: 16488436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of experimental Haemophilus influenzae type b bacteremia and endotoxemia by means of an immunolimulus assay.
    Mertsola J; Cope LD; Munford RS; McCracken GH; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):353-8. PubMed ID: 1856484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
    Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
    J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.
    Angus DC; Yang L; Kong L; Kellum JA; Delude RL; Tracey KJ; Weissfeld L;
    Crit Care Med; 2007 Apr; 35(4):1061-7. PubMed ID: 17334246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased release of sMD-2 during human endotoxemia and sepsis: a role for endothelial cells.
    Wolfs TG; Dunn-Siegrist I; van't Veer C; Hodin CM; Germeraad WT; van Zoelen MA; van Suylen RJ; Peutz-Kootstra CJ; Elson G; Pugin J; Buurman WA
    Mol Immunol; 2008 Jun; 45(11):3268-77. PubMed ID: 18384879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
    Emonts M; Sweep FC; Grebenchtchikov N; Geurts-Moespot A; Knaup M; Chanson AL; Erard V; Renner P; Hermans PW; Hazelzet JA; Calandra T
    Clin Infect Dis; 2007 May; 44(10):1321-8. PubMed ID: 17443469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipopolysaccharide- and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in sepsis.
    Saha DC; Astiz ME; Eales-Reynolds LJ; Rackow EC
    Shock; 2012 Jul; 38(1):43-8. PubMed ID: 22575995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
    Tang Y; Lv B; Wang H; Xiao X; Zuo X
    Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone].
    Wang HM; Cao WF; Peng YZ; Xiao GX; Yang XY
    Zhonghua Shao Shang Za Zhi; 2004 Apr; 20(2):95-7. PubMed ID: 15312472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating monocytes are not the major source of plasma cytokines in patients with sepsis.
    Gille-Johnson P; Smedman C; Gudmundsdotter L; Somell A; Nihlmark K; Paulie S; Andersson J; Gårdlund B
    Shock; 2012 Dec; 38(6):577-83. PubMed ID: 23143060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.
    Bates DW; Parsonnet J; Ketchum PA; Miller EB; Novitsky TJ; Sands K; Hibberd PL; Graman PS; Lanken PN; Schwartz JS; Kahn K; Snydman DR; Moore R; Black E; Platt R
    Clin Infect Dis; 1998 Sep; 27(3):582-91. PubMed ID: 9770160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxemia and endotoxin tolerance in patients with ARDS.
    Buttenschoen K; Kornmann M; Berger D; Leder G; Beger HG; Vasilescu C
    Langenbecks Arch Surg; 2008 Jul; 393(4):473-8. PubMed ID: 18320210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
    BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent effects of tumor necrosis factor-alpha and lymphotoxin-alpha on lethal endotoxemia and infection with live Salmonella typhimurium in mice.
    Dharmana E; Keuter M; Netea MG; Verschueren IC; Kullberg BJ
    Eur Cytokine Netw; 2002; 13(1):104-9. PubMed ID: 11956028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.
    Cheng SC; Scicluna BP; Arts RJ; Gresnigt MS; Lachmandas E; Giamarellos-Bourboulis EJ; Kox M; Manjeri GR; Wagenaars JA; Cremer OL; Leentjens J; van der Meer AJ; van de Veerdonk FL; Bonten MJ; Schultz MJ; Willems PH; Pickkers P; Joosten LA; van der Poll T; Netea MG
    Nat Immunol; 2016 Apr; 17(4):406-13. PubMed ID: 26950237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine colostrum as a biologic in clinical medicine: a review--Part II: clinical studies.
    Struff WG; Sprotte G
    Int J Clin Pharmacol Ther; 2008 May; 46(5):211-25. PubMed ID: 18538107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.